Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
Active, not recruiting · NCT03134118 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma, thymoma type B3 | Active, not recruiting | Phase 2 | 2026-05-15 | NCT03134118 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ETOP IBCSG Partners Foundation | 17 |
| European Organisation for Research and Treatment of Cancer - EORTC | 54 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.